GRCE Grace Therapeutics, Inc.
$2.22▼ -1.77%
Healthcare
Other
After hours
$2.22▲ +0.00%
Sep 11, 7:30 PM ET
Volume 716.0K
Avg Volume (10D) 150.2K
Key Metrics & Fundamentals
Market Cap
$46.70M
P/E Ratio
–
Div Yield
–%
52W Range
1.79 - 5.18
% vs 50 MA
-0.79%
% vs 200 MA
-27.36%
RSI-14
54.7
MACD Histogram
+0.0200
Beta (1Y vs SPY)
0.80
Free Cash Flow
-$3.22M
Gross Rev
$0
Gross Profit
$0
EBITDA
$11.17M
COGS
–
Operating Exp
$2.38M
Operating Income
-$2.38M
EBIT
-$2.38M
Pretax Income
-$15.79M
Net Income
-$15.79M
EPS (Diluted)
-0.91
Price & Volume History
Loading chart…
Recent News
Grace Therapeutics to Participate in the H.C. Wainright 28th Annual Global Investment Conference
GlobeNewswire · Sep 3, 2026 12:00 PM
Grace Therapeutics Files for Resale of Up to 4.8 Million Shares
MT Newswires · Aug 24, 2026 8:40 PM
Grace Therapeutics Announces First Quarter 2027 Financial Results, Provides Business Update
GlobeNewswire · Aug 13, 2026 12:00 PM
Grace Therapeutics Announces $10 Million Private Placement
GlobeNewswire · Aug 5, 2026 1:00 AM
Grace Therapeutics Announces Receipt of Type A Meeting Minutes from U.S. Food and Drug Administration
GlobeNewswire · Jul 28, 2026 11:00 AM
Grace Therapeutics Announces 2026 Fiscal Year-End Financial Results, Provides Business Update
GlobeNewswire · Jun 18, 2026 12:00 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See GRCE's money flow as a full page
Social Sentiment
No Reddit posts found for GRCE.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.